10/27/2026
New publication alert! Medical Director of PPP's Sana Clinic Dr. Jessica Meisner is Principal Investigator on this study for Open Forum Infectious Diseases about the success of long-acting injectable antiretroviral therapy as a catalyst for engagement in opioid use disorder treatment among people with HIV who use drugs. Thanks to Dr. Meisner, her co-authors, and all the PPP staff who contributed to this research. Thanks especially to our patients, who help protect their entire community when they take action to improve their individual health and wellness.
"Overall, these findings support integrated, low-barrier care models that treat HIV and OUD simultaneously rather than siloed conditions. In settings with high overdose mortality and unmet need for MOUD, initiation of LA-ART may represent a strategic opportunity to strengthen engagement across both treatment cascades. The observed temporal patternโrapid MOUD uptake following CAB+RPV initiation with concurrent reductions in opioid useโsuggests that LA-ART may serve as a key intervention point for enhancing engagement in substance use treatment."